Home/Filings/4/0001555667-14-000083
4//SEC Filing

SOLAZYME INC 4

Accession 0001555667-14-000083

CIK 0001311230operating

Filed

Sep 23, 8:00 PM ET

Accepted

Sep 24, 5:24 PM ET

Size

7.2 KB

Accession

0001555667-14-000083

Insider Transaction Report

Form 4
Period: 2014-09-22
Wolfson Jonathan S
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2014-09-22$8.05/sh30,000$241,3892,360,475 total(indirect: By Trust)
Holdings
  • Common Stock

    (indirect: By Trust)
    8,751
  • Common Stock

    153,750
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.22, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]Includes 128,750 shares previously owned directly by Mr. Wolfson that were contributed to the Jonathan S. Wolfson Revocable Trust dated August 12, 2010.
  • [F4]The Jonathan S. Wolfson Revocable Trust dated August 12, 2010.
  • [F5]Excludes 128,750 shares previously owned directly by Mr. Wolfson that were contributed to the Jonathan S. Wolfson Revocable Trust dated August 12, 2010.
  • [F6]The Wolfson Revocable Trust dated August 12, 2010.

Issuer

SOLAZYME INC

CIK 0001311230

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001311230

Filing Metadata

Form type
4
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:24 PM ET
Size
7.2 KB